Pelin Aytan

ORCID: 0000-0002-4213-1565 · 4 papers in corpus
other 2026
Is systemic inflammation associated with reduced ovarian reserve in endometriosis? An investigation of anti-Müllerian hormone and inflammatory markers
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.70610

OBJECTIVE: To examine the correlation between levels of anti-Müllerian hormone (AMH)-which serves as an indicator of ovarian reserve-and inflammation markers in women with endometriomas. METHODS: This retrospective investigation involved 9…

preprint 2026
Prognostic Value of Systemic Inflammatory Markers in Patients with Endometrioid-Type Endometrial Cancer: A Retrospective Analysis
·doi:10.21203/rs.3.rs-8414305/v1

Abstract Background Systemic inflammatory markers have emerged as prognostic indicators in various malignancies. This study investigates the relationship between preoperative inflammatory markers and survival outcomes in patients with end…

article 2007
Peroxisome proliferator‐activated receptor‐gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model
The Australian & New Zealand journal of obstetrics & gynaecology ·doi:10.1111/j.1479-828x.2007.00744.x

BACKGROUND: The effect of rosiglitazone, an activator of peroxisome proliferator-activated receptor-gamma, on the growth of ectopic uterine tissue was assessed. METHODS: Endometriosis was surgically induced in 28 rats by transplanting an au…

article 2005
Effect of Peroxisome Proliferator—Activated Receptor-γ Agonist Rosiglitazone on the Induction of Endometriosis in an Experimental Rat Model
Journal of the Society for Gynecologic Investigation ·doi:10.1016/j.jsgi.2005.10.002

ObjectiveTo assess the effect of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist rosiglitazone on the induction of endometriosis in a rat model.MethodsEndometriosis was surgically induced in 28 rats by transplanting an a…